These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 30213464)
41. Clinical significance of miR-22 expression in patients with colorectal cancer. Zhang G; Xia S; Tian H; Liu Z; Zhou T Med Oncol; 2012 Dec; 29(5):3108-12. PubMed ID: 22492279 [TBL] [Abstract][Full Text] [Related]
42. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
44. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients. Qian J; Zeng L; Jiang X; Zhang Z; Luo X Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680 [TBL] [Abstract][Full Text] [Related]
45. Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissue-specific prognostic factor. Wang S; Yang MH; Wang XY; Lin J; Ding YQ Int J Clin Exp Pathol; 2014; 7(6):3498-503. PubMed ID: 25031782 [TBL] [Abstract][Full Text] [Related]
46. Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas. Ardila HJ; Sanabria-Salas MC; Meneses X; Rios R; Huertas-Salgado A; Serrano ML Mol Clin Oncol; 2019 Aug; 11(2):201-207. PubMed ID: 31316774 [TBL] [Abstract][Full Text] [Related]
47. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma. Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080 [TBL] [Abstract][Full Text] [Related]
48. miR-1260b is a Potential Prognostic Biomarker in Colorectal Cancer. Liu DR; Guan QL; Gao MT; Jiang L; Kang HX Med Sci Monit; 2016 Jul; 22():2417-23. PubMed ID: 27399918 [TBL] [Abstract][Full Text] [Related]
49. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517 [TBL] [Abstract][Full Text] [Related]
50. Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis. Sharma B; Randhawa V; Vaiphei K; Gupta V; Dahiya D; Agnihotri N J Steroid Biochem Mol Biol; 2021 Apr; 208():105822. PubMed ID: 33465419 [TBL] [Abstract][Full Text] [Related]
51. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
53. Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery. Rotelli MT; Di Lena M; Cavallini A; Lippolis C; Bonfrate L; Chetta N; Portincasa P; Altomare DF Int J Colorectal Dis; 2015 Jul; 30(7):891-8. PubMed ID: 25989926 [TBL] [Abstract][Full Text] [Related]
54. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses. Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512 [TBL] [Abstract][Full Text] [Related]
55. Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer. Ghanbari R; Mosakhani N; Asadi J; Nouraee N; Mowla SJ; Poustchi H; Malekzadeh R; Knuutila S Cancer Biomark; 2015; 15(2):189-95. PubMed ID: 25519020 [TBL] [Abstract][Full Text] [Related]
56. Molecular detection of exosomal miRNAs of blood serum for prognosis of colorectal cancer. Bakhsh T; Alhazmi S; Farsi A; Yusuf AS; Alharthi A; Qahl SH; Alghamdi MA; Alzahrani FA; Elgaddar OH; Ibrahim MA; Bahieldin A Sci Rep; 2024 Apr; 14(1):8902. PubMed ID: 38632250 [TBL] [Abstract][Full Text] [Related]
57. A panel of microRNA signature in serum for colorectal cancer diagnosis. Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881 [TBL] [Abstract][Full Text] [Related]
59. Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer. Schee K; Lorenz S; Worren MM; Günther CC; Holden M; Hovig E; Fodstad O; Meza-Zepeda LA; Flatmark K PLoS One; 2013; 8(6):e66165. PubMed ID: 23824282 [TBL] [Abstract][Full Text] [Related]
60. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]